Modeling prostate cancer in the mouse

Affiliations

Review

D H Castrillon et al. Adv Cancer Res. 2001.

. 2001:82:187-204.

doi: 10.1016/s0065-230x(01)82006-6.

¹ Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts, USA.

No abstract available

Similar articles

A transgenic mouse prostate cancer model.
Gingrich JR, Greenberg NM. Gingrich JR, et al. Toxicol Pathol. 1996 Jul-Aug;24(4):502-4. doi: 10.1177/019262339602400414. Toxicol Pathol. 1996. PMID: 8864193 No abstract available.
Mouse models of prostate carcinogenesis.
Abate-Shen C, Shen MM. Abate-Shen C, et al. Trends Genet. 2002 May;18(5):S1-5. doi: 10.1016/s0168-9525(02)02683-5. Trends Genet. 2002. PMID: 12047956 Review.
The C3(1)/SV40 T antigen transgenic mouse model of prostate and mammary cancer.
Shibata MA, Jorcyk CL, Liu ML, Yoshidome K, Gold LG, Green JE. Shibata MA, et al. Toxicol Pathol. 1998 Jan-Feb;26(1):177-82. doi: 10.1177/019262339802600121. Toxicol Pathol. 1998. PMID: 9502400 Review. No abstract available.
Mouse models of prostate cancer.
Sharma P, Schreiber-Agus N. Sharma P, et al. Oncogene. 1999 Sep 20;18(38):5349-55. doi: 10.1038/sj.onc.1203037. Oncogene. 1999. PMID: 10498888 Review.
A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells.
Garabedian EM, Humphrey PA, Gordon JI. Garabedian EM, et al. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15382-7. doi: 10.1073/pnas.95.26.15382. Proc Natl Acad Sci U S A. 1998. PMID: 9860977 Free PMC article.

Prostatic intraepithelial neoplasia in genetically engineered mice.
Park JH, Walls JE, Galvez JJ, Kim M, Abate-Shen C, Shen MM, Cardiff RD. Park JH, et al. Am J Pathol. 2002 Aug;161(2):727-35. doi: 10.1016/S0002-9440(10)64228-9. Am J Pathol. 2002. PMID: 12163397 Free PMC article.